848488-91-5

Basic information

• Product Name: (R)-1-N-BOC-PIPECOLAMIDE
• Synonyms: N-Boc-D-2-piperidinecarboxamide;(R)-2-Carbamoyl-piperidine-1-carboxylic acid tert-butyl ester;(R)-1-Boc-2-piperidinecarboxaMide;(R)-tert-butyl 2-carbamoylpiperidine-1-carboxylate;1-Piperidinecarboxylic acid, 2-(aminocarbonyl)-, 1,1-dimethylethyl ester, (2R)-;(R)-tert-Butyl 2-carbamoyllpiperidine-1-carboxylate;(R)-1-Boc-2-(aminocarbonyl)piperidine
• CAS NO: 848488-91-5
• Molecular Formula: C11H20N2O3
• Molecular Weight: 228.29
• Mol File: 848488-91-5.mol

Chemical Properties

• Boiling Point: 384.4 °C at 760 mmHg
• Flash Point: 186.3 °C
• Appearance: /
• Density: 1.123 g/cm³
• Vapor Pressure: 4.1E-06mmHg at 25°C
• Refractive Index: 1.498
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: (R)-1-N-BOC-PIPECOLAMIDE(CAS DataBase Reference)
• NIST Chemistry Reference: (R)-1-N-BOC-PIPECOLAMIDE(848488-91-5)
• EPA Substance Registry System: (R)-1-N-BOC-PIPECOLAMIDE(848488-91-5)

Safety Data

• Hazardous Substances Data: 848488-91-5(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
(R)-1-N-BOC-PIPECOLAMIDE is used as a key intermediate in the synthesis of various pharmaceuticals for its ability to improve the stability and reactivity of the compounds being developed. Its role in creating peptide-based drugs makes it an indispensable component in the formulation of new medicinal compounds.
Used in Organic Chemistry Research:
(R)-1-N-BOC-PIPECOLAMIDE is used as a valuable tool in organic chemistry for the development of new chemical structures. Its properties as a building block and the presence of the BOC protecting group make it suitable for exploring novel organic molecules with potential applications in various fields.
Used in Medicinal Chemistry:
(R)-1-N-BOC-PIPECOLAMIDE is used as a precursor in the design and synthesis of new medicinal compounds, leveraging its anti-inflammatory and immunomodulatory properties derived from its parent compound, pipecolic acid. This makes it a promising candidate for the development of innovative therapeutic agents.

InChI:InChI=1/C11H20N2O3/c1-11(2,3)16-10(15)13-7-5-4-6-8(13)9(12)14/h8H,4-7H2,1-3H3,(H2,12,14)/t8-/m1/s1

Upstream product

• 28697-17-8 N-BOC-D-pipecolic acid 

Downstream Products

• 111478-74-1 (R)-2-(aminomethyl)piperidine 
• 1089729-74-7 (R)-2-[4-(4-chloro-phenyl)-thiazol-2-yl]-piperidine 
• 1089729-80-5 (R)-2-[4-(4-chloro-phenyl)-thiazol-2-yl]-piperidinium trifluoroacetate 
• 1089729-26-9 1-{(R)-2-[4-(4-Chloro-phenyl)-thiazol-2-yl]-piperidin-1-yl}-2-phenoxy-ethanone 
• 1089729-31-6 (R)-2-phenoxy-1-(2-(4-(pyridin-2-yl)thiazol-2-yl)piperidin-1-yl)ethan-1-one 
• 1089729-72-5 (R)-2-thiocarbamoyl-piperidine-1-carboxylic acid tert-butyl ester 
• 940000-26-0 1,1-dimethylethyl (2R)-2-cyano-1-piperidinecarboxylate 

Relevant articles and documents

IAP ANTAGONISTS AND THEIR THERAPEUTIC APPLICATIONS

The present invention relates to Formula I. compounds including their isomers, tautomeric forms and rotamers, salts together with their manufacturing process and their pharmacological use alone or in combination with other active ingredients for the treatment of cell and tissue malignances caused diseases, including uncontrolled cell or tissue growth, proliferation and cancer.

CYCLIC AMINE DERIVATIVE AND MEDICAL USE THEREOF

A cyclic amine derivative represented by general Formula (I): wherein R1 represents an alkyl group having 1 to 3 carbon atoms; A represents a group represented by general Formula (II-1), (II-2), or (II-3): R2 represents a hydrogen at

Small Molecule Inhibitors of Metabolic Enzymes Repurposed as a New Class of Anthelmintics

The enormous prevalence of infections caused by parasitic nematodes worldwide, coupled to the rapid emergence of their resistance to commonly used anthelmintic drugs, presents an urgent need for the discovery of new drugs. Herein, we have identified several classes of small molecules with broad spectrum activity against these pathogens. Previously, we reported the identification of carnitine palmitoyltransferases (CPTs) as a representative class of enzymes as potential targets for metabolic chokepoint intervention that was elucidated from a combination of chemogenomic screening and experimental testing in nematodes. Expanding on these previous findings, we have discovered that several chemical classes of known small molecule inhibitors of mammalian CPTs have potent activity as anthelmintics. Cross-clade efficacy against a broad spectrum of adult parasitic nematodes was demonstrated for multiple compounds from different series. Several analogs of these initial hit compounds were designed and synthesized. The compounds we report represent a good starting point for further lead identification and optimization for development of new anthelmintic drugs with broad spectrum activity and a novel mechanism of action.

PIPERIDINE-AMIDE DERIVATIVES

The invention is concerned with novel piperidine-amide derivatives of formula (I) wherein R1, R2, X and Y are as defined in the description and in the claims, as well as physiologically acceptable salts and esters thereof. These comp

POLYCYCLIC CARBAMOYLPYRIDONE DERIVATIVE HAVING HIV INTEGRASE INHIBITORY ACTIVITY

The present invention is to provide a novel compound (I), having the anti-virus activity, particularly the HIV integrase inhibitory activity, and a drug containing the same, particularly an anti-HIV drug, as well as a process and an intermediate thereof. Compound (I) wherein Z1 is NR4; R1 is hydrogen or lower alkyl; X is a single bond, a hetero atom group selected from O, S, SO, SO2 and NH, or lower alkylene or lower alkenylene in which the hetero atom group may intervene; R2 is optionally substituted aryl; R3 is hydrogen, a halogen, hydroxy, optionally substituted lower alkyl etc; and R4 and Z2 part taken together forms a ring, to form a polycyclic compound, including e.g., a tricyclic or tetracyclic compound.

THERAPEUTIC COMPOUNDS: PYRIDINE AS SCAFFOLD

Compounds of formulas I, IA, and IB or IC or pharmaceutically acceptable salts thereof: wherein A, A1, A2, A3, A4, R2, R3, R4 and n are as defined in the specifications well as salts and pharmaceutical compositions including the compounds are prepared. They are useful in therapy, in particular in the management of pain.